Item 1 of 1 (back to results) alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta.

Current search: 03. Biological Effects of Specific Chemicals: epitope [CHEBI:53000] > alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  epitope [CHEBI:53000] (470)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   chalcogen molecular entity [CHEBI:33304] (15225)   oxygen molecular entity [CHEBI:25806] (14414)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1)  trisaccharide derivative [CHEBI:63571] (187)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1)  organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1)  trisaccharide derivative [CHEBI:63571] (187)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1)  carbon group molecular entity [CHEBI:33582] (23847)   organic molecular entity [CHEBI:50860] (23769)   heteroorganic entity [CHEBI:33285] (15197)   organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1)  trisaccharide derivative [CHEBI:63571] (187)   amino trisaccharide [CHEBI:59266] (137)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp [CHEBI:62273] (2)   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp [CHEBI:72467] (1) ChEBI Compound Accession Identifier:   [CHEBI:72467] ChEBI Compound Description:   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta. ChEBI Compound Identification Number:   72467 ChEBI InChI Value:   InChI=1S/C23H39NO20/c25-2-7(30)12(32)18-11(24-10(31)5-28)6(29)1-23(43-18,22(38)39)44-19-13(33)8(3-26)41-21(16(19)36)42-17-9(4-27)40-20(37)15(35)14(17)34/h6-9,11-21,25-30,32-37H,1-5H2,(H,24,31)(H,38,39)/t6-,7+,8+,9+,11+,12+,13-,14+,15+,16+,17+,18+,19-,20+,21-,23-/m0/s1 ChEBI InChIKey Value:   FGYWXADXUBZTCC-RRDLSPBXSA-N ChEBI Compound Name:   alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp ChEBI SMILES Value:   [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(=O)CO)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO ChEBI Substance ID:   160962937 ChEBI URL:   ChEBI:72467 ChemSpider ID:   NS Ontomatica Chemical Accession Key (OnChAKey):   FGYWXADXUBZTCC_RRDLSPBXSA_N_000_000000 PubChem Compound ID:   70789003